Center for Vaccine Development Needs Young Volunteers for Influenza Vaccine Study

Influenza continues to be a major threat to human health. Every year, thousands of people in the U.S. alone die from complications of influenza infection. 

Effective vaccines have been available for the past 50 years, and are currently recommended to be given annually due to the change in the types of flu that circulate over time.

This research study will evaluate the safety of an investigational flu M2SR vaccine and the body’s immune response after receipt of both the investigational and licensed flu vaccine.

Vaccination is currently the most effective way of controlling flu and preventing its illness and complications. Vaccines can help prevent illness by causing the body to make antibodies that fight infection. If you are exposed to the flu virus after receiving the flu shot, the antibodies can help to protect you by fighting off the flu virus. As a result, you may not get sick at all or you may have a much shorter or milder illness.

Important Information

• Study participants must be between 9-17 years old.
• The study will last 13 months.
• There will be seven clinic visits and two phone calls.
• Participants will be compensated $75 a visit and $10 a phone call.

The risks and benefits will be discussed prior to enrolling in the study

For more information about the study, please contact the Vaccine Center at vaccine@slu.edu or at 314-977-6333 or 1-866-410-6333 (toll free). Please refer to Study 326, IRB 258011.